NCT06061718View on ClinicalTrials.gov

Travoprost Intraocular Implant in Conjunction With Cataract Surgery

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

March 18, 2024

Study Completion Date

December 20, 2024

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

iDose TR

anchored intracameral implant containing travoprost

Trial Locations (1)

Unknown

Glaukos Clinical Study Site, Yerevan

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY